Laprituximab Emtansine Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5626E
Add to Compare
$1,071.00 - $4,627.00
Delivery Time : 4 weeks

Laprituximab Emtansine Biosimilar - Research Grade

Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
ERBB1 / EGFR / HER1
Concentration
1mg/ml
Isotype
IgG1
Host
CHO Cells
Uniprot
P00533
Shipping Conditions
Room Temp
Background
EGFR (also known as ERBB1 or HER1) is a receptor tyrosine kinase whose overexpression fuels growth in numerous carcinomas, a property that has long motivated targeted payload-delivery strategies. Supplied as a human IgG1, this product is an unconjugated, non-therapeutic analog of laprituximab emtansine, intended to support antibody-drug-conjugate (ADC) research without any payload or linker attached. It is purified to a low-endotoxin grade compatible with in vivo studies and produced in scalable milligram-to-gram lots for demanding, high-throughput workflows. For research use only (RUO), it serves as a naked-antibody comparator and binding reference in ADC characterization, internalization assays, and preclinical EGFR tumor models.
Other Names
DM1
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
1 week
Write Your Own Review
You're reviewing:Laprituximab Emtansine Biosimilar - Research Grade
Your Rating
Back to Top